Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis

Nephrology Dialysis Transplantation

Volumn 13, Issue 8, 1998, Pages 2074-2076

  Haubitz, Marion ^a   Koch, Karl M ^a   Brunkhorst, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ANCA associated vasculitis; Cyclosporin; Relapse

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HERPES ZOSTER; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHOLESTEROL; CYCLOSPORINE; FEMALE; HERPES ZOSTER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME; TRIGLYCERIDES; VASCULITIS;

EID: 0031823479     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.8.2074     Document Type: Article

References (18)

1. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-498
2. Nachman PH, Hogan SI, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 33-39
3. Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology and renal outcome. Clin Nephrol 1991; 35: 139-147
4. Gaskin G, Pusey CD. Evaluation of a policy to prevent vasculitis relapse. Clin Exp Immunol 1995; 101 [Suppl.]: 46
5. De Groot K, Reinhold-Keller E, Tatsis E et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Arthritis Rheum 1996; 39: 2052-2061
6. Nowack R, Birck R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 1997; 349: 774
7. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis. Clin Exp Immunol 1994; 98: 448-453
8. Griffith ME, Coulthart A, Pusey CD. T cell responses to myeloperoxidase and proteinase 3 in patients with systemic vasculitis. Clin Exp Immunol 1996; 103; 253-258
9. Gutfleisch J, Baumert E, Wolff-Vorbeck G, Schlesier M, Strutz HJ, Peter HH. Increased expression of CD 25 and adhesion molecules on peripheral blood lymphocytes of patients with Wegener's granulomatosis and ANCA positive vasculitides. Adv Exp Med Biol 1993; 336: 397-404
10. Schlesier M, Kaspar T, Gutfleisch J. Activated CD4+ and CD8+ T cell subsets in Wegener's granulomatosis. Rheumatol Int 1995; 14: 213-219
11. Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM. Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 1993; 91: 415-420
12. Ho S, Clipstone N, Timmermann L et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996; 8: 40-45
13. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides: proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-192
14. Haubitz M, Kliem V, Koch KM et al. Renal transplantation for patients with autoimmune diseases. Single-center experience of 42 patients. Transplantation 1997; 63: 1251-1257
15. Hagen EC, De Keizer RJW, Andrassy K et al. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin Nephrol 1995; 43: 351-359
16. Lockwood CM, Thiru S, Isaacs J, Hale G, Waldman H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993; 341: 1620-1622
17. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim/sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazol Wegener Study Group. N Engl J Med 1996; 335: 16-20
18. Reinhold-Keller E, De Groot K, Rudert H, Nölle B, Heller M, Gross WL. Response to trimethoprim/sulphamethoxazole in Wegener's granulomatosis depends on the phase of disease. Q J Med 1996; 89: 115-123